AMNEAL PHARMACEUTICALS, INC. AMRX
19.77
(0.04)
(0.20%)
as of 25 Sep
- Market cap
- $6.3B
- P/E
- 39.5×
Follow AMRX
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (395.84%) | (137.24%) | (79.69%) | (5.80%) |
+8 more TTM periods Free account |
|
| 4.37% | 3.54% | 2.01% | 0.17% | ||
ROIC |
11.05% | 11.44% | 11.25% | 10.04% | |
Return on Tangible Assets |
10.35% | 8.06% | 4.89% | 0.42% | |
Average Days of Receivables |
119.51 | 102.02 | 108.29 | 110.25 | |
Free Cash Flow per Share |
(0.04) | 0.60 | 0.73 | 0.76 | |
Free Cash Flow |
(11.59) | 189.67 | 227.73 | 237.88 | |
Capital Expenditures |
(212.37) | (116.17) | (112.26) | (89.87) | |
Piotroski F-Score |
8.00 | 7.00 | 8.00 | 8.00 | |
| Other line items | |||||
Cash ROIC |
7.07% | 10.99% | 12.09% | 12.14% | |
Accounts Receivable Turnover |
3.41 | 3.79 | 3.61 | 3.57 | |
Accounts Payable Turnover |
2.73 | 2.89 | 2.55 | 2.65 | |
Inventory Turnover |
2.94 | 3.01 | 3.13 | 3.07 | |
Average Days of Payables |
139.15 | 129.52 | 145.83 | 143.92 | |
Days of Inventory on Hand |
130.81 | 125.35 | 116.14 | 120.85 | |
Tax Rate |
0.07 | 0.00 | (0.08) | (0.16) | |
Research and Development Expense of Revenue |
5.63% | 6.06% | 6.17% | 7.01% | |
Selling, General and Administrative Expense of Revenue |
18.34% | 17.97% | 17.45% | 17.34% | |
Share Based Compensation of Revenue |
1.14% | 1.10% | 1.06% | 1.05% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.28 | 2.50 | 4.72 | 55.55 | |
Depreciation/Fixed assets |
0.46 | 0.51 | 0.56 | 0.61 | |
Capex/Depreciation |
(1.01) | (0.51) | (0.46) | (0.34) | |
Revenue per Share |
9.77 | 9.64 | 9.63 | 9.34 | |
Operating CF per Share |
0.63 | 0.97 | 1.09 | 1.04 | |
Capex per Share |
(0.67) | (0.37) | (0.36) | (0.29) | |
Capex to Sales |
0.07 | 0.04 | 0.04 | 0.03 | |
Net Profit Margin |
5.05% | 4.01% | 2.39% | 0.20% |
Columns are period end dates